MEDYSN Email Formats

Biotechnology Research • Spring, Texas, United States • 1-10 Employees

Key Contact at MEDYSN

Dylan Cloud

Founder & CEO

Company overview

Headquarters	Spring, Texas, United States
NAICS	541714
Keywords	Neurotechnology, Regenerative Medicine, Pharmaceutical Manufacturing, Neuromodulation, Translational Neuroscience, Ai-Driven Drug Discovery, Appetite Regulation & Metabolic Disorders, Biotech Device Development, Closed-Loop Systems & Feedback Interfaces, Drug Repurposing & Reformulation, Osteoporosis Innovation, Precision Dosing & Pharmacogenomics, Space & Zero-Gravity Medicine
Founded	2024
Employees	1-10

About MEDYSN

MEDYSN is a translational neuroscience and biotechnology company focused on solving neglected clinical challenges through precision innovation. We develop high impact, clinically viable solutions that larger players often overlook, including noninvasive neuromodulation technologies, next generation therapeutics, advanced pharmaceutical manufacturing, diagnostics, and precision delivery systems. Our mission is to close the gap between unmet medical needs and frontier science. Through interdisciplinary R&D, strategic partnerships, and a patient first mindset, we turn bold hypotheses into real world breakthroughs. MEDYSN operates at the intersection of neuroscience, biotechnology, and clinical care, where innovation meets urgency. For partnership or research inquiries, contact Dylan at dylan@medysn.com.